X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
metastasis (6) 6
oncology (6) 6
humans (5) 5
index medicus (5) 5
male (5) 5
abiraterone acetate (4) 4
aged (4) 4
docetaxel (4) 4
double-blind method (4) 4
hematology, oncology and palliative medicine (4) 4
prostate cancer (4) 4
adult (3) 3
aged, 80 and over (3) 3
androstadienes - administration & dosage (3) 3
cancer (3) 3
care and treatment (3) 3
corticosteroids (3) 3
men (3) 3
middle aged (3) 3
patient outcomes (3) 3
prednisone (3) 3
prednisone - administration & dosage (3) 3
prostatic neoplasms, castration-resistant - drug therapy (3) 3
prostatic neoplasms, castration-resistant - pathology (3) 3
research (3) 3
survival (3) 3
analysis (2) 2
androstadienes - therapeutic use (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bone neoplasms - secondary (2) 2
chemotherapy (2) 2
clinical-trials (2) 2
disease progression (2) 2
enzalutamide (2) 2
inhibitor (2) 2
mitoxantrone plus prednisone (2) 2
neoplasm metastasis (2) 2
oncology, experimental (2) 2
pain measurement (2) 2
prostatic neoplasms - drug therapy (2) 2
prostatic neoplasms - pathology (2) 2
prostatic neoplasms, castration-resistant - mortality (2) 2
recommendations (2) 2
steroids (2) 2
therapy (2) 2
treatment outcome (2) 2
urology & nephrology (2) 2
working group (2) 2
activities of daily living (1) 1
androgen antagonists - administration & dosage (1) 1
androstadienes - adverse effects (1) 1
androstenes - therapeutic use (1) 1
antineoplastic agents, hormonal - administration & dosage (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antitumor-activity (1) 1
australia (1) 1
bone (1) 1
bone neoplasms - complications (1) 1
bone neoplasms - drug therapy (1) 1
bone neoplasms - mortality (1) 1
cabazitaxel (1) 1
canada (1) 1
cancer patients (1) 1
castration (1) 1
clinical importance (1) 1
combination (1) 1
comparative analysis (1) 1
controlled trial (1) 1
cost of illness (1) 1
cox models (1) 1
cyp17 (1) 1
disease (1) 1
double-blind (1) 1
drug administration schedule (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
end-points (1) 1
europe (1) 1
follow-up studies (1) 1
fractures, spontaneous - etiology (1) 1
fractures, spontaneous - prevention & control (1) 1
glucocorticoids - administration & dosage (1) 1
immpact recommendations (1) 1
impact (1) 1
kaplan-meier estimate (1) 1
laboratory marker (1) 1
liver cancer (1) 1
liver metastases (1) 1
medical research (1) 1
metastatic prostate cancer (1) 1
mitoxantrone (1) 1
neoplasm grading (1) 1
neoplasm staging (1) 1
orchiectomy (1) 1
original (1) 1
original article (1) 1
outcomes (1) 1
pain (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 152 - 160
Journal Article
Lancet Oncology, ISSN 1470-2045, 2013, Volume 14, Issue 12, pp. 1193 - 1199
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 12, pp. 1210 - 1217
Journal Article
Clinical Genitourinary Cancer, ISSN 1558-7673, 02/2018, Volume 16, Issue 1, pp. 72 - 77.e1
Prognostic models are needed to address the wide spectrum of clinical conditions in chemotherapy-naïve mCRPC. We developed a model that categorized patients... 
Statistical regression | Cox models | Metastasis | Risk group | Laboratory marker | PLACEBO-CONTROLLED PHASE-3 | WORKING GROUP | ONCOLOGY | RECOMMENDATIONS | CLINICAL-TRIALS | MEN | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | ENZALUTAMIDE
Journal Article
Prostate Cancer and Prostatic Diseases, ISSN 1365-7852, 2014, Volume 17, Issue 1, pp. 34 - 39
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.